Publications by authors named "Derrick Stobaugh"

Claim this Profile
D
Determinants of Palliative Care Utilization Among Patients Hospitalized With Metastatic Gastrointestinal Malignancies.
Philip N Okafor, Derrick J Stobaugh, Augustine K Nnadi, Jayant A Talwalkar

Am J Hosp Palliat Care· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic Inequalities in the Utilization of Colorectal Stents for the Treatment of Malignant Bowel Obstruction.
Philip N Okafor, Derrick J Stobaugh, Louis M Wong Kee Song, Paul J Limburg, Jayant A Talwalkar

Dig Dis Sci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
African Americans Have Better Outcomes for Five Common Gastrointestinal Diagnoses in Hospitals With More Racially Diverse Patients.
Philip N Okafor, Derrick J Stobaugh, Michelle van Ryn, Jayant A Talwalkar

Am J Gastroenterol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors.
Parakkal Deepak, Derrick J Stobaugh

Clin Gastroenterol Hepatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis.
Asha Krishnan, Derrick J Stobaugh, Parakkal Deepak

Rheumatol Int· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
Derrick J Stobaugh, Parakkal Deepak

Ann Pharmacother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.
Michael R McKenna, Derrick J Stobaugh, Parakkal Deepak

J Gastrointestin Liver Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
Derrick J Stobaugh, Parakkal Deepak, Eli D Ehrenpreis

J Am Acad Dermatol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting System.
Parakkal Deepak, Derrick J Stobaugh, Eli D Ehrenpreis

J Gastrointestin Liver Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample.
Derrick J Stobaugh, Parakkal Deepak, Eli D Ehrenpreis

Clin Exp Gastroenterol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA Adverse Event Reporting System.
Allison Salk, Derrick J Stobaugh, Parakkal Deepak, Eli D Ehrenpreis

Drug Saf· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.
Derrick J Stobaugh, Parakkal Deepak, Eli D Ehrenpreis

Eur J Clin Pharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Allison Salk, Derrick J Stobaugh, Parakkal Deepak, Eli D Ehrenpreis

Ann Pharmacother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis.
Derrick J Stobaugh, Parakkal Deepak, Matthew Thorpe, Bruce Hannon, Eli D Ehrenpreis

Inflamm Bowel Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Parakkal Deepak, Humberto Sifuentes, Muhammed Sherid, Derrick Stobaugh, Yama Sadozai

Am J Gastroenterol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wheel running can accelerate or delay extinction of conditioned place preference for cocaine in male C57BL/6J mice, depending on timing of wheel access.
Martina L Mustroph, Derrick J Stobaugh, Daniel S Miller, Erin K DeYoung, Justin S Rhodes

Eur J Neurosci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis